https://www.prnewswire.co.uk/news-releases/pharmaleads-reports-positive-phase-i-sad-data-with-its-dual-enkephalinase-inhibitor-denki-pl265-for-the-631462793.html
Pharmaleads Reports Positive Phase I SAD Data with its Dual ENKephalinase Inhibitor (DENKI) PL265...
/PRNewswire/ -- Pharmaleads, an emerging pharmaceutical company developing innovative products for the management of acute and chronic severe pain, today...